Ernexa Therapeutics appoints Robert J. Spiegel, M.D. to board of directors

Ernexa Therapeutics Inc.

Appointment effective September 14, 2026; Dr. Spiegel serves until next election or earlier departure.
Compensation follows Board of Directors Compensation Plan adopted August 15, 2026, per Q2 10-Q.
No arrangements, family relationships, or Item 404(a) reportable transactions disclosed.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Robert J. Spiegel

Director

ERNA · Ernexa Therapeutics Inc.

Effective: 2026-09-14
Filed: September 16, 2026, 4:50 PM ET

approved the appointment of Robert J. Spiegel, M.D. to serve as a member of the Board, effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Robert J. Spiegel was appointed as Director at Ernexa Therapeutics Inc..

Action: appointed
Role: Director

Exact text from the filing

approved the appointment of Robert J. Spiegel, M.D. to serve as a member of the Board, effective immediately.

View on SEC.gov

Ernexa Therapeutics Inc. filing history →

Source: SEC EDGAR

accession 0001493152-26-042934

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.